Cogent Biosciences, Inc. (COGT) Social Stream



Cogent Biosciences, Inc. (COGT): $11.06

-0.26 (-2.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add COGT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 385

in industry

COGENT BIOSCIENCES INC (COGT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering COGT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-11 7 $31 $15 $21.428 $12.98 65.08%
2022-02-08 7 $31 $14 $20.571 $12.98 58.48%
2022-03-16 7 $31 $14 $20.428 $12.98 57.38%
2022-05-10 6 $23 $14 $19 $12.98 46.38%
2022-06-09 6 $23 $14 $18.166 $12.98 39.95%
2022-06-17 6 $23 $15 $18.333 $12.98 41.24%
2022-07-27 7 $23 $15 $17.857 $12.98 37.57%
2022-08-08 7 $23 $15 $18.571 $12.98 43.07%
2022-08-09 6 $22 $15 $19.5 $12.98 50.23%
2022-11-02 5 $28 $15 $20.5 $12.98 57.94%
2022-11-14 6 $28 $15 $20.333 $12.98 56.65%
2022-12-12 6 $28 $15 $20 $12.98 54.08%
2022-12-14 7 $28 $18 $21.857 $12.98 68.39%
2023-02-07 7 $28 $18 $22.142 $12.98 70.59%

The Trend in the Analyst Price Target


COGT's average price target has moved up $1.94 over the prior 25 months.

COGT reports an average of 132.38% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-28 6 23 14 19.000 6.510 191.86%
2022-06-01 6 23 14 18.166 4.255 326.93%
2022-08-08 7 23 15 18.571 12.600 47.39%
2023-01-05 7 28 18 22.142 12.000 84.52%
2023-01-26 7 28 18 22.142 14.750 50.12%

COGT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.14 6 1 0 0 0 7

The Trend in the Broker Recommendations


Over the past 92 days, COGT's average broker recommendation rating worsened by 0.14.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, COGENT BIOSCIENCES INC's average analyst price target is higher than 440.82% of them.
  • In the context of all US stocks, COGENT BIOSCIENCES INC's number of analysts covering the stock is greater than 632.08% of them.
  • In terms of how COGENT BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 491.13% of that group.
  • COGT has a lower variance in analysts' estimates than -601.74% of Pharmaceutical Products stocks.

Stocks similar to COGENT BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are UBX, FIXX, and BTAI.

Is COGT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6827 seconds.